About: Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2003 (uk) مقالة علمية تنشرت ف 1 أكتوبر 2003 (ary) im Oktober 2003 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 2003 (ast) scientific article published on 01 October 2003 (en)
publication date	wds:Q73783125-A02FA716-6674-433B-8D17-B4C435360570
publication date	2003-10-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q73783125-0BE65588-8FDB-44C3-B5B6-76DAA1C5ECF2 wds:Q73783125-0C844089-80A0-4C5A-B1BF-F45E9473F751 wds:Q73783125-19CD8D2C-70DF-41CB-8C70-A3454177A698 wds:Q73783125-4B27ADC1-C18C-4A4F-AA06-22F5A7480F62 wds:Q73783125-51543C68-DA11-4CDF-AA49-F864650F6527 wds:Q73783125-6FA5AB2D-B47E-46F5-8880-5DAF332D57E6 wds:Q73783125-90E7E535-808E-4A59-A249-6C6E385916A0 wds:Q73783125-BE008051-549E-46E1-9359-C496C38BE3B4 wds:Q73783125-C4DF5818-DBBF-4294-85AD-D692D6B6327D wds:Q73783125-C4EC5577-8BDC-4D54-87CE-801BE84FC50F wds:Q73783125-DED8C1B6-DBF5-4389-86F0-82718A554C54 wds:Q73783125-FD300F5A-0973-414D-BCDB-CE393EAB00B3
cites work	Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer HER-2/neu expression: a major prognostic factor in endometrial cancer Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin Salivary neoplasms: overview of a 35-year experience with 2,807 patients Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group Malignant salivary tumors--analysis of prognostic factors and survival c-erbB-2/neu oncogene and Ki-67 analysis in the assessment of palatal salivary gland neoplasms Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancer
author name string	wds:Q73783125-5450AB39-8E0A-4FC9-9EDC-96DB48FC7FF0 wds:Q73783125-6790B906-E4CE-4BC0-B4DE-D3438D11859A wds:Q73783125-78A96999-E6CC-49A3-BE3F-BF83BA2BD5D3 wds:Q73783125-7EE91260-11D6-4146-A13A-F48A0407DDCF wds:Q73783125-8DFFD26D-E2E9-47FE-B026-86B2D226B89B wds:Q73783125-9D3FF152-01C7-4F45-9BF8-8C7F2AD2EEA1 wds:Q73783125-C6156C7B-C510-4E4F-B0F3-E953124C011C wds:Q73783125-D12B9601-FABF-4FD6-BD61-6EC7F9E42641 wds:Q73783125-EB25094B-F857-4F4F-8766-879F26287E6D
author name string	Robert Haddad Philip C Amrein Rosemary Costello A Dimitrios Colevas Marshall Posner Bonnie Glisson Dennis Cooper Jeffrey F Krane Linda Weeks
rdfs:label	Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study (en) Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study (nl)
skos:prefLabel	Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study (en) Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study (nl)
name	Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study (en) Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study (nl)
title	wds:Q73783125-3B48F575-3DCB-4D98-808F-850E311E8A20
title	Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study (en)
page(s)	wds:Q73783125-66D70EAC-707A-4DCD-B3F9-43B1755C4CF4
page(s)	724-727
instance of	wds:Q73783125-534701BF-B8EB-4503-B072-9AEEB0534D8B
instance of	scholarly article
PubMed ID	wds:Q73783125-99EA782A-EAA6-4C3C-AFA2-3010EDB021D2
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12907212
PubMed ID	12907212
published in	wds:Q73783125-BD0EB8F0-FEEE-4A49-8AA6-14DC01FE58A4
published in	Oral Oncology
issue	wds:Q73783125-86D99134-BF4D-4BE6-A742-161CB3522827
volume	wds:Q73783125-1FE4682B-D260-47C1-9A62-1FB4D5DDB80B
issue	7
volume	39
DOI	wds:Q73783125-E9F9D5B1-6980-48D5-9CA4-EBFE27C8FF21
DOI	http://dx.doi.org/10.1016/S1368-8375(03)00097-6
DOI	10.1016/S1368-8375(03)00097-6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73783125
is cites work of	Salivary gland cancers: biology and molecular targets for therapy. Expression of matrix metalloproteinase-1, -7, -9, -13, Ki-67, and HER-2 in epithelial-myoepithelial salivary gland cancer Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology Recent trends in the management of minor salivary gland carcinoma. Salivary mucoepidermoid carcinoma revisited. Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma Close association between HER-2 amplification and overexpression in human tumors of non-breast origin Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer Genomic landscape of salivary gland tumors HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review Heparanase expression in malignant salivary gland tumors inversely correlates with long-term survival HER2 expression in cervical cancer as a potential therapeutic target Human epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma Correlations of Human Epithelial Growth Factor Receptor 2 Overexpression with MUC2, MUC5AC, MUC6, p53, and Clinicopathological Characteristics in Gastric Cancer Patients with Curative Resection Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling Salivary gland carcinomas Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software